Skyrizi (risankizumab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Skyrizi (risankizumab), covering 2026-03-16 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab [Phase 3]